Targeting PD-1/PD-L1 in lung cancer: current perspectives
{{output}}
Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/... ...